Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Postmenopausal Women With Advanced Breast Cancer
Interventions: DRUG: Letrozole
Sponsor: Novartis Pharmaceuticals
Collaborators: Chugai Pharmaceutical